Regional intestinal permeability in rats of compounds with different physicochemical properties and transport mechanisms
- PMID: 9255712
- DOI: 10.1111/j.2042-7158.1997.tb06093.x
Regional intestinal permeability in rats of compounds with different physicochemical properties and transport mechanisms
Abstract
Because the absorption of orally administered drugs depends on intestinal permeability, we have investigated how absorptive capacity varies from the proximal to distal intestine in rats. The effective permeabilities of compounds with a range of physicochemical properties and different absorption mechanisms were estimated by use of a previously validated in-situ, single-pass perfusion model. The low colonic permeabilities of D-glucose and L-dopa indicate the absence or low capacity of the glucose- and amino-acid-transporters in this region. With the exception of the small and moderately lipophilic non-steroidal anti-inflammatory drug, naproxen, for which permeability was maintained throughout the intestine, the passive intestinal permeabilities for hydrophilic and lipophilic drugs were approximately twice as high in the jejunum and ileum as in the colon. These observations are in accord with those made in recent studies. However, the reasons for the high colonic permeability of non-steroidal anti-inflammatory drugs, and results obtained in previous animal experiments demonstrating that the colon is the region of the intestine with the highest absorptive capacity were not fully clarified. These data show that the permeability to hydrophilic and lipophilic drugs decreases along the intestine, whereas it is maintained throughout the intestine for the small and moderately lipophilic naproxen. Further investigations are required to clarify the interplay between membrane composition, fluidity and permeability under various conditions in different absorption models.
Similar articles
-
Concentration- and region-dependent intestinal permeability of fluvastatin in the rat.J Pharm Pharmacol. 1998 Jul;50(7):737-44. doi: 10.1111/j.2042-7158.1998.tb07134.x. J Pharm Pharmacol. 1998. PMID: 9720622
-
Jejunal permeability and hepatic extraction of fluvastatin in humans.Clin Pharmacol Ther. 1996 Nov;60(5):493-503. doi: 10.1016/S0009-9236(96)90145-9. Clin Pharmacol Ther. 1996. PMID: 8941022
-
Site of drug absorption after oral administration: assessment of membrane permeability and luminal concentration of drugs in each segment of gastrointestinal tract.Eur J Pharm Sci. 2006 Nov;29(3-4):240-50. doi: 10.1016/j.ejps.2006.06.004. Epub 2006 Jun 27. Eur J Pharm Sci. 2006. PMID: 16876987
-
Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model.Pharm Res. 2006 Aug;23(8):1675-86. doi: 10.1007/s11095-006-9041-2. Pharm Res. 2006. PMID: 16841194 Review.
-
Intestinal permeability and its relevance for absorption and elimination.Xenobiotica. 2007 Oct-Nov;37(10-11):1015-51. doi: 10.1080/00498250701704819. Xenobiotica. 2007. PMID: 17968735 Review.
Cited by
-
Regional Intestinal Drug Permeability and Effects of Permeation Enhancers in Rat.Pharmaceutics. 2020 Mar 8;12(3):242. doi: 10.3390/pharmaceutics12030242. Pharmaceutics. 2020. PMID: 32182653 Free PMC article.
-
Dynamic analysis of GI absorption and hepatic distribution processes of telmisartan in rats using positron emission tomography.Pharm Res. 2012 Sep;29(9):2419-31. doi: 10.1007/s11095-012-0768-7. Epub 2012 May 23. Pharm Res. 2012. PMID: 22618800
-
Levodopa-Carbidopa Intestinal Gel Pharmacokinetics: Lower Variability than Oral Levodopa-Carbidopa.J Parkinsons Dis. 2017;7(2):275-278. doi: 10.3233/JPD-161042. J Parkinsons Dis. 2017. PMID: 28211816 Free PMC article. Clinical Trial.
-
Influence of osmolality on gastrointestinal fluid volume and drug absorption: potential impact on oral salt supplementation.J Pharm Health Care Sci. 2021 Sep 1;7(1):29. doi: 10.1186/s40780-021-00212-z. J Pharm Health Care Sci. 2021. PMID: 34465382 Free PMC article.
-
Rat jejunal permeability and metabolism of mu-selective tetrapeptides in gastrointestinal fluids from humans and rats.Pharm Res. 1997 Dec;14(12):1780-5. doi: 10.1023/a:1012144232666. Pharm Res. 1997. PMID: 9453068
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources